Transit-1: Evaluation Of Transition From Inhaled Treprostinil To Oral Selexipag

被引：0
|
作者：
Frost, A. [1 ]
Benza, R. L. [2 ]
Farber, H. [3 ]
Kim, N. H. [4 ]
Hartline, B. K. [5 ]
Pfister, T. [6 ]
Shiraga, Y. [6 ]
McLaughlin, V. [7 ]
机构：
[1] Houston Methodist Lung Ctr, Houston, TX USA
[2] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[3] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA
[4] Univ Calif San Diego, Pulm & Crit Care Med, San Diego, CA 92103 USA
[5] Actel Pharmaceut US Inc, San Francisco, CA USA
[6] Actel Pharmaceut Ltd, Allschwil, Switzerland
[7] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3977
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Transition from treprostinil to selexipag in patients with pulmonary arterial hypertension: Case series
    Fanous, Sherif M.
    Janmohamed, Munir
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (23) : 1877 - 1881
  • [22] Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension
    Asuka Furukawa
    Yuichi Tamura
    Hiroya Iwahori
    Masato Goto
    Narutaka Ohashi
    Teruo Okabe
    Akio Kawamura
    [J]. BMC Pulmonary Medicine, 17
  • [23] Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension
    Furukawa, Asuka
    Tamura, Yuichi
    Iwahori, Hiroya
    Goto, Masato
    Ohashi, Narutaka
    Okabe, Teruo
    Kawamura, Akio
    [J]. BMC PULMONARY MEDICINE, 2017, 17
  • [24] Safety And Tolerability Of Outpatient Transition Of Parenteral And Inhaled Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension
    Khan, A. A.
    Ackerbauer, K.
    Tandon, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [25] Transition from intravenous treprostinil to enteral selexipag in an infant with pulmonary arterial hypertension
    Koo, Rachel
    Lo, Jennifer
    Bock, Matthew J.
    [J]. CARDIOLOGY IN THE YOUNG, 2019, 29 (06) : 849 - 851
  • [26] TRANSITIONING FROM INHALED ILOPROST TO ORAL SELEXIPAG: A CASE REPORT
    Bhura, Sajeer
    Gibbons, William
    [J]. CHEST, 2019, 156 (04) : 741A - 741A
  • [27] A SUCCESSFUL RAPID TRANSITION FROM ORAL TREPROSTINIL TO SELEXIPAG IN A PATIENT WITH PULMONARY ARTERIAL HYPERTENSION AND LIMITED CUTANEOUS SYSTEMIC SCLEROSIS
    Gabriel, John Taylor
    Diwan, Johnell
    Markin, Catherine
    [J]. CHEST, 2020, 158 (04) : 2097A - 2097A
  • [28] Real-World Transitions From Oral To Inhaled Treprostinil
    Migliore, C.
    D'Albini, L.
    Messick, C. R.
    Gordon, K. W.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [29] Real-World Transitions From Inhaled To Oral Treprostinil
    D'Albini, L.
    Broderick, M.
    Zaccardelli, J. G.
    Gordon, K. W.
    Rischard, F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [30] Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Bourge, Robert C.
    Tapson, Victor F.
    Safdar, Zeenat
    Benza, Raymond L.
    Channick, Richard N.
    Rosenzweig, Erika B.
    Shapiro, Shelley
    White, Richard James
    McSwain, Christopher Shane
    Gotzkowsky, Stephen Karl
    Nelsen, Andrew C.
    Rubin, Lewis J.
    [J]. CARDIOVASCULAR THERAPEUTICS, 2013, 31 (01) : 38 - 44
12345